Delivery Order SPE2DB24D1201-SPE2DB25FJBJD

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,749.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMBIEN CR 6.25 MG TABLET 100S, a prescription medication, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,926.86 delivery order contract is for the provision of AMBIEN CR 6.25 MG TABLET 100S, a sleep medication. The contract has a firm fixed price pricing type and a completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,635.91 delivery order contract is for the supply of AMBIEN CR 12.5 MG TABLET 100S, a prescription sleep medication. The contract has an ultimate completion date of November 5, 2024 and is a firm fixed price arrangement. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,049.47, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific order is for AMBIEN CR 6.25 MG...
This federal contract award, valued at $4,605.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC), valued at $999,999,999, that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $1,104.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ambien CR 6.25 mg tablets, a medication used for the treatment of insomnia. The award is a delivery order contract, with a firm fixed-price pricing type. It has an ultimate completion date of July 9, 2024. Amerisourcebergen Drug Corp is the prime contractor, and...
This federal contract award, valued at $5,387.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of AMBIEN CR 12.5 MG TABLET 100S, a prescription sleep medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,279.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of AMBIEN CR 6.25 MG TABLET 100S, a prescription sleep medication. The award has an ultimate completion date of October 30, 2024 and is structured as a Firm Fixed Price Delivery Order. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award, valued at $3,595.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $7,437.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMBIEN CR 6.25 MG TABLET 100S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of November 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJBJD
    Delivery Order

This federal contract award, valued at $1,447.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMBIEN CR 6.25 MG TABLET 100S, a type of sleeping medication, to support military healthcare programs. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to the military. The contract does not have a set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's significant role in supplying critical medical commodities, including specialty medications, generic drugs, and medical devices, to various federal healthcare programs, particularly those serving military personnel and veterans.

Generated 4/29/25, 9:55 AM